Treatment strategy for cutaneous apocrine carcinoma
Dai Ogata(Unknown), Masako Kasami(Shizuoka Cancer Center), Yoshio Kiyohara(Shizuoka Cancer Center), Shusuke Yoshikawa(Kyushu University)
Cited by 41
Related Papers
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
|Annals of Oncology|2020|140
Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
|Journal of Dermatological Science|2015|120